To: "optimal@xxxxxxxxxxxxx" <optimal@xxxxxxxxxxxxx>
Date: Fri, 24 Apr 2015 16:34:33 +0000
Hello colleagues,
I have received an inquiry from the UK about how often Spectralis users in the
US enter the c-curve information when imaging clinical patients, not just in
clinical trials.
